What NHS access is likely to look like If retatrutide is approved by NICE for NHS use, eligibility is likely to follow the pattern set by Mounjaro
doi: 10.1016/j.taap.2013.03.026
In a study of more than 3,000 adults with obesity, the highest dose of orforglipron resulted in an average weight loss of 27.3 pounds over 72 weeks, with a safety profile consistent with injectable GLP-1s
The treatment can also improve kidney function, lower the risk of cardiovascular events like heart attacks and strokes, and enhance blood sugar regulation
Fortino is dedicated to supporting your long-term health through personalized, results-driven care
This helps you feel full longer, reduces appetite, slows digestion, and may quiet food noise (constant thoughts about eating)